Skip to headlines
clockwire Search
LIVE
Cheapest place to shop for Thanksgiving groceries in Charlotte in 2026 President, PM pay tribute to Armed Forces martyrs on Armed Forces Day Badoc town in Ilocos Norte declared drug-cleared municipality How many must burn? Impeachment motion against Supreme Court chief likely to be initiated on 2nd anniversary of martial law bid: lawmaker The week in photos: November 14-20, 2026 Indonesia promotes film and game industries in Bali village MK Stalin's Second Coming? Kolathur Conqueror Dead, All Eyes On Bypoll James Harden drops 51 on Pacers, moves into third in NBA history in 50-point games Moschino secures come-from-last win in Dunstan Breeders Stakes at Pukekohe Wild gaur falls into waste tank in Keralam’s Pathanamthitta, rescue efforts on Figure skating: GP Series debutant Shimada leads at Finlandia Trophy Belgian Word of the Day: Ambetant Siya Kolisi explains to Irish why 'dramatic' Springboks carry hopes of every South African Labor set for historic defeat at Victorian election, political experts say
‹ Back to your news
New drug combo shrinks tumors in most patients facing aggressive cancer type

HEALTH

New drug combo shrinks tumors in most patients facing aggressive cancer type

Covered by 1 source Earliest report we found

How each outlet tells it

Fox News (US) · private

New drug combo shrinks tumors in most patients facing aggressive cancer type

New drug combo shrinks tumors in most patients facing aggressive cancer type

The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.

Read at Fox News